Applications for this meeting must be submitted by May 6, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.
GRS Speaker Abstract Deadline: Although applications will be accepted until the date noted above, any applicants who wish to be considered for an oral presentation should submit their application by March 27, 2017. Please refer to the application instructions in the Meeting Description section below for more details (if available).
The Gordon Research Seminar on Preclinical Form and Formulation for Drug Discovery is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of this
meeting is on recent progress in understanding and new strategies in preclinical drug
development including conventional formulations as well as novel therapies. Discussion
topics include, but are not limited to, new approaches in enhancing solubility
of poorly-soluble drugs, protein stability, targeted drug delivery, and new analytical
methodologies. Additionally, experts in academia and industry will share their
experience and provide a general perspective on the future of pharmaceutical research.
The meeting will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The Chairs will select speakers from abstracts submitted by March 27, 2017. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Deadline section above.
- Introductory Comments: 3:30 pm - 3:45 pm
- Introductory Science Session: 3:45 pm - 4:30 pm
- Poster Session I: 4:30 pm - 6:00 pm
- Dinner: 6:00 pm - 7:00 pm
- Evening Science Session: 7:30 pm - 9:30 pm
- Breakfast: 7:30 am - 8:30 am
- Morning Science Session: 9:00 am - 11:00 am
- Poster Session II: 11:00 am - 12:30 pm
- Lunch: 12:30 pm - 1:30 pm
- Concluding Science Session: 1:30 pm - 2:30 pm
- Evaluation Period: 2:30 pm - 3:00 pm
- Program for related GRC begins: 6:00 pm
This GRS will be held in conjunction with the "Preclinical Form & Formulation for Drug Discovery" Gordon Research Conference (GRC)
. Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page
for more information.
Preliminary Program Outline
An outline of the program components for this GRS is displayed below. The Conference Chair is currently developing their detailed program schedule, which will include the speakers they select from submitted abstracts, in addition to any additional components outlined below. The detailed program will be available by April 3, 2017. Please check back for updates.
Nicholas Warne (Pfizer, USA)
- To Be Selected from Submitted Abstracts
Sachin Lohani (Johnson & Johnson, USA)
Adora Padilla (GSK Vaccines, USA)
Yongchao Su (Merck Research Laboratories, USA)
Narayan Variankaval (Merck Research Laboratories, USA)
Additional Discussion Leaders May Be Selected from Submitted Abstracts
Annette Bak (AstraZeneca, USA)
Robert Berendt (U.S. Food and Drug Administration, USA)
Elizabeth Topp (Purdue University, USA)